Our customers include pharmaceutical and biotechnology companies, laboratories,
academic and research institutions, public health authorities, private healthcare
organizations, doctors and government agencies. Our quarterly revenue and results
of operations are highly dependent on the volume and timing of orders received
during the quarter. In addition, our revenues and earnings forecasts for future
quarters are often based on the expected trends in our markets. However, the markets
we serve do not always experience the trends that we may expect. Negative fluctuations
in our customers’ markets, the inability of our customers to secure credit
or funding, restrictions in capital expenditures, general economic conditions,
cuts in government funding or unfavorable changes in government regulations would
likely result in a reduction in demand for our products and services. In addition,
government funding is subject to economic conditions and the political process,
which is inherently fluid and unpredictable. Our revenues may be adversely affected
if our customers delay or reduce purchases as a result of uncertainties surrounding
the approval of government or industrial funding proposals. Such declines could
harm our consolidated financial position, results of operations, cash flows and
trading price of our common stock, and could limit our ability to sustain profitability.
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
COMPANY NAME
MARKET CAP
REVENUES
INCOME
EMPLOYEES
0.00
0.00
0.00
-
SUBTOTAL
0.00
0.00
0.00
-
Sources:
’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: ’s corporate clients.
For your research, we’ve provided 9 tables on corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
